Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

The FDA has granted Fast Track designation to amezalpat (TPST-1120) for the treatment of patients with hepatocellular carcinoma.